  Psoriasis is a skin inflammatory<disease> disease<disease> characterized by an increased body of comorbidities , including parodontopathy. Despite the visibility of skin<symptom> lesions<symptom> , prognostic biomarkers , related to disease monitoring and therapeutic effectiveness , are still missing. Although several markers have been studied , none of them has been identified as an independent prognostic factor. This concise review aims to summarize the current knowledge and results in saliva research applied to psoriasis. Combination of different markers could improve the prognostic prediction in patients with psoriasis. Future studies are needed to implement research on salivary biomarkers and their prognostic/therapeutic effects in the management of patients with psoriasis.